Pharmaceutical care for a child with severe pneumonia infected by MP combined with hMPV and SP
The clinical pharmacists participated in the pharmaceutical care of a child with severe pneumonia infected by Myocoplasima pneumonia(MP)combined with human metapneumovirus(hMPV)and streptococcus pneumonia(SP)throughout the entire process.In cases where the physicians ignored MP,used off-label drug,and violated traditional theory of drug combination with the complex disease,the clinical pharmacists timely provided safe and effective analyses and suggestions of the treatment plan,monitored the efficacies and adverse reactions,and provided medication guidance through searching for information and in-depth analyses of the disease situation.It ensured the safety and effectiveness of medication for the child effectively,provided the effective pharmaceutical services for clinical practice,and provided reference for drug treatment and care of such patients at the same time.
Mycoplasma pneumoniaHuman metapneumovirusStreptococcus pneumoniaSevere pneumoniaChildPharmaceutical care
万方数据
维普
